Getting a message from your pharmacy that your prescription needs "step therapy" before it can be filled is one of the more confusing moments in dealing with health insurance. The drug your doctor chose isn't denied forever — but it isn't covered yet either, and the letter explaining why is usually written in language built for compliance departments, not patients.
Step therapy exists across nearly every type of coverage — employer plans, ACA marketplace plans, Medicare Part D, and Medicaid managed care — and it applies to some of the most commonly prescribed drug categories: biologics for autoimmune conditions, GLP-1 medications, specialty pain treatments, and more. The rules for overriding it are more standardized than most patients realize, largely because state legislatures have spent the last decade writing step therapy reform laws specifically to rein in overly rigid insurer policies.
This guide walks through exactly what a step therapy requirement means, the specific grounds you can use to request an exception, how long insurers have to respond, and what to do if that first request gets denied.
What "Step Therapy" Actually Means
Step therapy is a utilization management tool. Instead of covering every prescribed drug at face value, the insurer sets up a sequence — a "step" — for a given condition. You typically have to try the first-line option (usually a generic or lower-cost preferred drug) before the plan will pay for a costlier, later-step alternative, even if your doctor believes the later-step drug is the better choice from the start.
| Term | What It Means |
|---|---|
| Step Therapy / "Fail First" | You must try a specific lower-cost drug before the plan covers the originally prescribed drug |
| Step Therapy Exception / Override | A formal request to skip the required step, based on documented medical grounds |
| Step Drug | The lower-cost, first-line medication the plan requires you to try first |
| Target Drug | The medication your doctor originally prescribed, which sits behind the step |
Why Insurers Use Step Therapy
Step therapy is primarily a cost-containment strategy, but insurers also frame it as an evidence-based safeguard — steering patients toward drugs with a longer track record before moving to newer, pricier options with less real-world data. Both things can be true at once, which is part of why the appeal process exists: to catch the cases where the generic sequencing doesn't fit an individual patient's history.
Step Therapy vs. Prior Authorization vs. Formulary Exclusion
These three terms get used interchangeably by patients, but they trigger different processes and different appeal strategies.
| Restriction Type | What Triggers It | How to Resolve It |
|---|---|---|
| Step Therapy | Drug is covered, but only after trying a required alternative first | Try the step drug, or request a documented exception |
| Prior Authorization | Drug requires upfront clinical justification regardless of prior treatments | Prescriber submits clinical documentation supporting medical necessity |
| Formulary Exclusion | Drug isn't on the plan's covered drug list at all | Request a formulary exception, arguing covered alternatives are inappropriate |
It's common for a single denial to combine more than one of these — for example, a specialty drug might require both prior authorization and step therapy. Reading the denial letter carefully to identify exactly which restriction applies (or all of them) determines which type of request you file. Our prior authorization guide covers that process in more detail if your denial letter mentions both.
The Exception Grounds Insurers Must Accept
Most state step therapy override laws, and Medicare Part D's exception process, are built around the same handful of recognized grounds. You don't need all of them — one solid, well-documented ground is usually enough.
The strongest single ground: Documented prior failure. If you've already tried the step drug — even years ago, even under different insurance — and your medical records show it didn't control your condition or caused a problem, that history is usually enough on its own to support an exception.
Drug Classes Where Step Therapy Is Most Common
Step therapy shows up disproportionately in a handful of drug categories. Knowing where your prescription sits helps you anticipate the requirement before you're standing at the pharmacy counter.
| Condition | Typical Step (First-Line) Drug | Typical Target Drug Behind the Step |
|---|---|---|
| Type 2 Diabetes / Weight Management | Metformin, generic sulfonylureas | GLP-1 agonists (semaglutide, tirzepatide) |
| Rheumatoid Arthritis / Autoimmune | Methotrexate or other conventional DMARDs | Biologic injectables (adalimumab, etanercept) |
| Chronic Pain | NSAIDs, generic non-opioid options | Brand-name or extended-release pain medications |
| Acid Reflux / GERD | Generic omeprazole or other OTC-strength PPIs | Brand-name prescription-strength PPIs |
| Diabetes (Insulin) | Older or lower-cost basal/rapid insulins | Newer analog insulins or insulin pump-compatible formulations |
Managing insulin costs specifically? Our insulin savings programs guide and manufacturer savings card guide cover how to reduce out-of-pocket costs even while a step therapy exception is pending.
Eligibility Comparison: Exception Request vs. Formal Appeal
These are two different tools, used at two different points in the process. Confusing them is one of the most common reasons patients lose time.
| Situation | Step Therapy Exception Request | Formal Appeal |
|---|---|---|
| Haven't received a denial yet, prescription just flagged | Use this first | Not yet applicable |
| Exception request was denied | Already used | Use this next |
| Need a fast decision due to urgent health risk | Request expedited review (24 hrs, Medicare) | Expedited appeal also available |
| Requires prescriber documentation | Yes — clinical justification required | Yes — plus the denial letter and prior records |
| Independent, non-insurer review available | No — reviewed by the plan itself | Yes — IRE (Medicare) or external review (commercial) |
Pros and Cons of Each Path Forward
Requesting an Exception — Pros
- Fast turnaround: 72 hours standard, 24 hours expedited
- No cost to file, and your prescriber handles most of it
- Can be submitted before you ever pay out of pocket
- Sets up a stronger record if a later appeal becomes necessary
Requesting an Exception — Cons
- Reviewed by the same plan that denied the drug initially
- Requires specific clinical documentation, not just a doctor's preference
- Approval isn't guaranteed even with a solid clinical case
- Weak or vague documentation is a common reason for denial
Trying the Step Drug First — Pros
- No paperwork, no waiting on a decision
- Often genuinely effective — step drugs aren't chosen at random
- Immediately establishes a documented trial if it doesn't work
- Usually the lower-cost option while insurance sorts itself out
Trying the Step Drug First — Cons
- Delays access to the drug your prescriber originally chose
- Not appropriate if there's a known contraindication or allergy
- May mean weeks of inadequate symptom control before switching
- Can feel like starting over if you've already tried it in the past
Real-World Examples
Example 1: Documented prior failure
Priya's rheumatologist prescribes a biologic for rheumatoid arthritis. Her commercial plan requires she try methotrexate first. Her records show she took methotrexate two years ago under a previous insurer and had to stop due to liver enzyme elevations.
Result: Her prescriber submits the lab records with the exception request, and it's approved within 72 hours on the "adverse reaction" ground.
Example 2: Medicare Part D GLP-1 step therapy
Robert's Medicare Part D plan requires metformin before covering a GLP-1 medication for type 2 diabetes. He's been on metformin for years without adequate blood sugar control, confirmed by recent A1C readings.
Result: His doctor requests a standard exception citing "expected to be ineffective," supported by the A1C trend, and it's approved within the 72-hour window.
Example 3: Exception denied, appeal succeeds
Denise's insurer denies her initial exception request for a specialty pain medication, stating the documentation didn't clearly identify which alternative she'd tried. Her doctor refiles with specific drug names, dates, and dosages from her chart, then escalates to a formal internal appeal when the plan still doesn't respond within the required window.
Result: The internal appeal is approved once the missing details from the first request are included.
How to Request an Exception, Step by Step
Read the denial or restriction notice carefully
Identify the exact drug being required as the "step," and note whether prior authorization is also involved. The notice should list the plan's specific step therapy criteria.
Gather your clinical history
Pull together dates, doses, and outcomes for any prior use of the step drug — pharmacy fill records and past chart notes are the strongest evidence here.
Have your prescriber select the right exception ground
Match your documentation to one of the recognized grounds: prior failure, expected ineffectiveness, adverse reaction risk, or medical inappropriateness.
Submit through the plan's exception request process
This is usually a specific form, fax number, or online portal — check your insurance card or plan website for the pharmacy benefits department contact.
Request expedited review if medically urgent
Your prescriber must certify in writing that waiting for the standard timeline could seriously jeopardize your health — this triggers the faster 24-hour Medicare timeline (or equivalent under commercial plans).
If denied, file a formal appeal immediately
Note the appeal deadline on your denial letter and don't let it lapse — most plans give 60 to 180 days, but urgent situations shouldn't wait that long.
Decision Tree: What Should You Do Right Now?
Step 1: Have you already tried the required step drug?
This determines your strongest available exception ground.
Pull the records
Dates, doses, and the outcome or side effect that occurred.
File an exception on "prior failure"
This is typically the fastest ground to get approved.
Is it contraindicated or expected to be ineffective?
Ask your prescriber for their clinical opinion in writing.
File on that ground, or try the step drug first
If there's no clear medical reason to skip it, trying it first is usually fastest.
If the exception is denied
File a formal internal appeal, then request independent external review (or IRE for Medicare) if needed.
Approval and Appeal Timelines
| Stage | Medicare Part D | Commercial / ACA Plans |
|---|---|---|
| Initial Exception Request | 72 hours standard / 24 hours expedited | 72 hours standard / 24 hours expedited (varies slightly by state) |
| First-Level Appeal (Redetermination / Internal Appeal) | 7 days standard / 72 hours expedited | 15 days pre-service / 30 days post-service; 72 hours if urgent |
| Independent Review | IRE: 7 days standard / 72 hours expedited | External review: up to 45 days standard / 72 hours expedited |
| Further Appeal Level | Administrative Law Judge (ALJ), if claim value threshold is met | Varies by state; some allow a second internal appeal before external review |
Deadlines are strict. Missing an appeal filing window can end your case regardless of how strong the medical argument is. Mark the deadline from your denial letter the day you receive it.
Does a Step Therapy Override Need to Be Renewed?
- Medicare Part D formulary exceptions generally last through the remainder of the plan year, but must be re-requested if you re-enroll or switch plans at the next open enrollment.
- Commercial plan exceptions can reset with a new plan year, a new employer group renewal, or a formulary update — check your renewal notice for changes to covered drugs.
- If your treatment is ongoing and stable, ask your prescriber to flag the exception in your chart so future renewal requests can reference the original approval and documentation.
- Switching insurers essentially restarts the process — a prior approval doesn't transfer, even if the clinical facts haven't changed.
If Your Appeal Fails: Income-Based Alternatives
Sometimes an exception and appeal both come back denied, or the process simply takes longer than you can wait. In that case, income-based assistance can bridge the gap while you continue pursuing coverage.
| Program | Typical Income Limit | What It Provides |
|---|---|---|
| Medicare Extra Help (Low-Income Subsidy) | ~150% FPL (varies by asset level) | Reduced Part D premiums, deductibles, and copays |
| Manufacturer Patient Assistance Programs | Typically 300–400% FPL, product-dependent | Free or heavily discounted medication directly from the manufacturer |
| State Pharmaceutical Assistance Programs | Varies by state | Supplemental drug coverage layered on top of existing insurance |
Our Patient Assistance Programs guide and Extra Help (LIS) eligibility guide walk through exact income thresholds and how to apply. Comparing GoodRx and Inside Rx pricing or checking our Drug Price Checker can also reveal a cash price lower than your copay while the appeal is pending.
Common Mistakes That Get Exceptions Denied
Nearly every denied exception request can be traced back to missing documentation rather than a truly unwinnable clinical case. Resubmitting with specific dates, doses, and outcomes resolves the majority of first-round denials.
Frequently Asked Questions
Step therapy, sometimes called "fail first," means your insurance plan requires you to try one or more lower-cost or preferred medications before it will cover the drug your doctor originally prescribed. If the lower-step drug doesn't work, isn't tolerated, or is inappropriate for you, you can typically request an exception to skip straight to the originally prescribed medication.
Your prescriber submits an exception request documenting one of the recognized grounds: the step drug already failed, is expected to be ineffective, would cause an adverse reaction, or is medically inappropriate for your condition. Specific dates, doses, and outcomes from any prior trial of the step drug make the strongest case.
For Medicare Part D plans, a standard exception request must be decided within 72 hours, or 24 hours if your doctor certifies the request as urgent. Commercial plans generally follow similar timelines under state step therapy override laws, though the exact number of hours can vary slightly by state.
A denied exception request can be appealed. For Medicare Part D, the next step is a redetermination, followed by review from an Independent Review Entity if needed. For commercial plans, you typically file an internal appeal first, then request an external review by an independent reviewer not affiliated with your insurer.
Most states now have step therapy reform laws requiring insurers to offer a clear override or exception process with defined response timelines, though the specific grounds and deadlines vary by state. A smaller number of states have no such law, leaving the process to each insurer's own policy.
Your doctor can write the prescription, but the pharmacy will still bill it through your insurance, which will reject the claim if step therapy applies and hasn't been satisfied or waived. Your options are to try the step drug, pay cash for the original prescription, or have your doctor file a documented exception request.
Yes, in most states. Medicaid managed care plans commonly use step therapy, and states generally require a comparable exception process, though the specific rules and appeal body differ from Medicare Part D and are set by the state Medicaid agency.
Yes, if you have a documented medical reason the step drug isn't appropriate — such as a known allergy, a drug interaction, or clinical evidence it's expected to be ineffective for your specific condition. You don't have to try and fail a drug you already know will cause harm.
Pharmacy fill records, old chart notes, or even a written summary from a previous prescriber describing the outcome can support this. There's no strict time limit on how old the prior trial can be, as long as the documentation clearly identifies the drug, dose, and result.
Yes. Once your plan approves the exception, it updates your coverage record, and the pharmacy should be able to process the original prescription on the next attempt. It's worth calling ahead to confirm before making a special trip.
Medicare Part D plans are required to provide a temporary transition supply in certain situations, such as when you're new to the plan or the drug was recently removed from the formulary. Commercial plans vary, so it's worth asking your plan directly whether a bridge supply applies to your situation.
Independent databases like NeedyMeds and BenefitsCheckUp can help you search for manufacturer, state, and nonprofit assistance programs by ZIP code and diagnosis while your appeal is still in progress.
How We Researched This Guide
References
- Centers for Medicare & Medicaid Services. Medicare Part D Coverage Determinations, Exceptions, and Appeals Guidance.
- Medicare.gov. How to File an Appeal.
- Centers for Medicare & Medicaid Services. Medicare Advantage Prior Authorization and Step Therapy Fact Sheet.
- U.S. Food and Drug Administration. Prescription Drug Labeling and Approved Indications.
- NeedyMeds. Independent Patient Assistance Program Directory.
- National Council on Aging. BenefitsCheckUp Assistance Program Search.
- Lilly Cares Foundation. Patient Assistance Program Overview.
- Novo Nordisk. NovoCare Patient Support and Cost Assistance Overview.
Related Resources
Related Insurance & Assistance Guides
- Prior Authorization: What It Means & How to Appeal
- Patient Assistance Programs (Complete 2026 Guide)
- Medicare Part D Coverage & the $35 Insulin Cap
- Medicare Extra Help (Low-Income Subsidy) Eligibility
- How Manufacturer Savings Cards Work
- Insulin Savings Programs Compared (2026)
- GoodRx vs. Inside Rx: Which Saves You More?
- Drug Price Checker
Editorial Policy: Refill Relay content is researched using publicly available CMS guidance, federal appeal regulations, and state step therapy override statutes. Every article is reviewed for clarity, accuracy and usefulness before publication. This content is educational and is not legal or medical advice.